Age and nature of operation influence the pharmacokinetics of midazolam

K. W. Harper, P. S. Collier, J. W. Dundee, P. Elliott, N. J. Halliday, K. G. Lowry

Research output: Contribution to journalArticle

60 Scopus citations

Abstract

The pharmacokinetics of midazolam were studied in surgical patients given 0.3 mg kg-1 i.v. for either the induction of anaesthesia, or postoperative sedation following cardiopulmonary bypass. The short elimination half-life of midazolam (2.4 h in patients < 50 yr undergoing minor surgery) was significantly, although not markedly, prolonged with age (4.1 h in patients > 50 yr undergoing minor procedures) and by the nature of the operation (3.8 h after major operative procedures). These changes were the result of alterations in clearance and volume of distribution with age, and in volume of distribution with nature of operation.

Original languageEnglish (US)
Pages (from-to)866-871
Number of pages6
JournalBritish Journal of Anaesthesia
Volume57
Issue number9
DOIs
StatePublished - Sep 1985

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Age and nature of operation influence the pharmacokinetics of midazolam'. Together they form a unique fingerprint.

  • Cite this

    Harper, K. W., Collier, P. S., Dundee, J. W., Elliott, P., Halliday, N. J., & Lowry, K. G. (1985). Age and nature of operation influence the pharmacokinetics of midazolam. British Journal of Anaesthesia, 57(9), 866-871. https://doi.org/10.1093/bja/57.9.866